CHICAGO — Late-stage outcomes of Novo Nordisk’s weight problems candidate CagriSema counsel the drug is akin to Eli Lilly’s Zepbound…
Read More
CHICAGO — Late-stage outcomes of Novo Nordisk’s weight problems candidate CagriSema counsel the drug is akin to Eli Lilly’s Zepbound…
Read More